• PRM1 Kaplan-Meier Survival Curves- A Potential Source of Data for Systematic Reviews

    Nov 1, 2012, 00:00

  • PCN106 Persistence in Patients With Breast Cancer Treated With Tamoxifen or Aromatase Inhibitors- Results of a Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PCV87 Factors Related to Non-Adherence and Satisfaction for Hypertension Medications- Results From a Novel Patient Registry

    Nov 1, 2012, 00:00

  • PIN14 Projecting the Clinical Impact of Treating Hepatitis C Genotype 1 Infection With Boceprevir in Germany

    Nov 1, 2012, 00:00

  • PND3 The Population-Based Impact of MS in Asia

    Nov 1, 2012, 00:00

  • PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PIH4 Immunization Status and Families' Factors in Iraq

    Nov 1, 2012, 00:00

  • PMH38 Assessing Depressive Symptoms in Primary Care- Psychometrical Properties of the Spanish Version of the Clinically Useful Depression Outcome Scale

    Nov 1, 2012, 00:00

  • PCV92 Comparison of the Psychometric Properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in Patients with Pulmonary Hypertension

    Nov 1, 2012, 00:00

  • PCV59 Where Did the Time Go?- Temporal Uncertainty in Cost-Effectiveness Decision Models

    Nov 1, 2012, 00:00

  • PRM88 Translation and Validation of Osteoporosis Health Belief Scale Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • HT3 Development of a Check List for Quality Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Taiwan

    Nov 1, 2012, 00:00

  • PHP31 Knowledge and Practice of Disposal of Date Expired and Unused Drugs

    Nov 1, 2012, 00:00

  • PND53 Patient Reported Sleep Problems in the UK

    Nov 1, 2012, 00:00

  • PIN35 Cost of Antimicrobial Prescribing Using a Large Pharmacy Database in South Africa

    Nov 1, 2012, 00:00

  • PRM152 Is it Just Semantics? The Use of “Efficacy” and “Effectiveness” in Comparative Effectiveness Reviews and Health Technology Assessments

    Nov 1, 2012, 00:00

  • PHP21 How Will the New NHS Decentralised Reforms Impact on Access to Medicines in England?

    Nov 1, 2012, 00:00

  • PRM154 Source Data Verification – A Survey of Current Practice

    Nov 1, 2012, 00:00

  • PHP83 The OTC Policy in Eyrope and Greece

    Nov 1, 2012, 00:00

  • PMD86 Inappropriate Use of Upper Gastrointestinal Endoscopy in Clinical Practices in Japan

    Nov 1, 2012, 00:00

  • PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • HC2 A Review of Economic Evaluations of New Drugs Priced by the Similar Drug Comparison Method in Japan- Did Cost-Effectveness Results Justify Premiums?

    Nov 1, 2012, 00:00

  • PHP40 AMNOG- Pricing Reforms in Action

    Nov 1, 2012, 00:00

  • PHP189 Trends in the Use of Innovative Contracting Models Between the Pharmaceutical Industry and Payers in Europe

    Nov 1, 2012, 00:00

  • PSS29 Assessing the Clinical Meaningfulness of 1-Line Average Change in Visual Acuity Among Patients With Diabetic Macular Edema- Evidence From Health-Related Quality of Life Changes

    Nov 1, 2012, 00:00

  • PCN23 Cancer Related Bisphosphonate Therapy in Different Treatment Facilities

    Nov 1, 2012, 00:00

  • PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes - A Population Based Study

    Nov 1, 2012, 00:00

  • PHP133 Market Access of Drugs in France and Medico-Economic Assessment

    Nov 1, 2012, 00:00

  • PRM78 Mapping of the National Eye Institute 25-Item Visual Functioning Questionnaire (VFQ-25) to EQ-5D Utility Scores

    Nov 1, 2012, 00:00

  • PCV33 Self-Reported Health Status Among Taiwanese Hypertensive Elderly

    Nov 1, 2012, 00:00

  • PIH31 Intentional and Unintentional Non-Adherence Differ Across Prevalent Conditions in a Russian Patient Population

    Nov 1, 2012, 00:00

  • PRS28 Cost-Effectiveness Analysis of Montelukast in 6-14-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus

    Nov 1, 2012, 00:00

  • PSS5 New Formulation of Travoprost Reduces Dry Eye Occurrence and Costs in Glaucoma Patients- Model-Based Results for Hong Kong

    Nov 1, 2012, 00:00

  • PDB36 An Evaluation of the Long-Term Costs and Effects of a 1% Reduction in HbA1C in Type 2 Diabetes Patients in Malaysia

    Nov 1, 2012, 00:00

  • PHS57 Comparing Predictors of Self-Reported Adherence to Mammography Screening Guidelines in Appalachian Women Who Utilize Mobile and Stationary Facilities

    Nov 1, 2012, 00:00

  • PSU12 Minimally Invasive Surgery in Spinal Fusion - Clinical and Economical Impact From Hospital Perspective

    Nov 1, 2012, 00:00

  • PMS4 Inhibition of Carrageenan-Induced Edema by Stachys Fruticulosa Extract in Rats

    Nov 1, 2012, 00:00

  • PMS68 The Use of Monitoring Systems to Better Regulate Drug Consumption in Hungarian Hospitals

    Nov 1, 2012, 00:00

  • PIN6 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C Treatment

    Nov 1, 2012, 00:00

  • PHP33 Drug-Related Problems and Length of Stay in the Management of Infection in Patients with Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PHP138 Impact of Value Based Pricing on Future of Patient Access Schemes in the UK

    Nov 1, 2012, 00:00

  • PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in Fran A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PSY16 Effect of the Anti-Tumor Necrosis Factor Adalimumab on Work Productivity in Patients With Chronic Immune-Mediated Inflammatory Diseases- Literature Review

    Nov 1, 2012, 00:00

  • PMS13 Cost-Effectiveness of Biological Treatments in Patients with Rheumatoid Arthritis in Taiwan

    Nov 1, 2012, 00:00

  • PRM15 Assessing the Broader Impact of Vaccinations- A Government Perspective Quantitative Analytic Framework Applied to Vaccination

    Nov 1, 2012, 00:00

  • PCN100 Cost Utility Analysis of Bortezomib in a Biomarker Positive Subgroup of Relapsed and Refractory Folicular Lymphoma

    Nov 1, 2012, 00:00

  • PRM63 Long-Term Burden of Asthma in Children With Allergic Rhinitis/ Conjunctivitis

    Nov 1, 2012, 00:00

  • PHP165 Exploring the Role of the Committee in the Nice Appraisal Process- How Consistent are Decisions Across Committees?

    Nov 1, 2012, 00:00

  • PCV67 Mind the Gap! Geographic Transferability of Economic Evaluation in Health

    Nov 1, 2012, 00:00

  • PRS12 Clinical COPD Questionnaire (CCQ)- Is There a Need to Develop a Specific English Version for the Philippines and India?

    Nov 1, 2012, 00:00

  • PHP56 Horizontal Equity in Primary Health Care Services in Times of Economic Crisis in Gree Ex Ante and Ex Post Findings

    Nov 1, 2012, 00:00

  • PCN65 Cost-Effectiveness Analysis of Introducing HPV Vaccines in Colombian Women

    Nov 1, 2012, 00:00

  • PRM108 Reliability, Validity, and Ability to Detect Change of the Fact-an for Use in Patients With Anaemia Associated With Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PCN95 Pharmacoeconomic Analysis of Direct Medical Costs Associated With the Treatment of Advanced Esophago-Gastric Cancer Therapy With Xeloda or 5-Fluorouracil (5-FU) Regimens- Implications for Health Care Utilisation in Australia

    Nov 1, 2012, 00:00

  • PMH57 HTA Landscape of Treatments Available for Alcohol-Related Disorders

    Nov 1, 2012, 00:00

  • PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

    Nov 1, 2012, 00:00

  • PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease Control

    Nov 1, 2012, 00:00

  • PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic Therapy

    Nov 1, 2012, 00:00

  • PDB28 Cost of Disease and its Relationship With Diabetic Complications in Turkish Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PHS5 Assessing the Clinical and Economic Burden of United States Veteran Ankylosing Spondylitis Patients

    Nov 1, 2012, 00:00

  • PCN44 Cost Comparison Analysis of Antibody Therapies in the Metastatic Colorectal Carcinoma

    Nov 1, 2012, 00:00

  • PHP8 A Survey of “Joint Working” Between the Pharmaceutical Industry and the National Health Service in the UK

    Nov 1, 2012, 00:00

  • PGI1 Acne Drug Therapy and the Development of Comorbid Inflammatory Bowel Disease in the United States

    Nov 1, 2012, 00:00

  • PRM23 Cost-Effectiveness Versus Patient Acceptability- The Exemplar of CFS/ME

    Nov 1, 2012, 00:00

  • PSS21 Evaluation of Health Utility in Patients With Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PSY13 Pilot Cost Study of Chronic Mieloid Leukemia Therapy

    Nov 1, 2012, 00:00

  • PND64 Quality of Life and Productivity Loss in Patients With Hereditary Angioedema (HAE) in Sweden; Results From a Retrospective Patient Registry Survey Implemented by Sweha-Reg (a Population Based Census of HAE in Sweden)

    Nov 1, 2012, 00:00

  • PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis

    Nov 1, 2012, 00:00

  • PCN13 Analysis of the Impact of Prophylactic Vaccination Against Human Papillomavirus Infection Using a Dynamic-Modelling Approach

    Nov 1, 2012, 00:00

  • PUK4 A Cost-Comparison Analysis of Treating Overactive Bladder (OAB) With Fesoterodine, Tolterodine or Solifenacin in Daily Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PCN135 The Economic Value of Medical Progress, the Case of Cancer in France (1990-2010)

    Nov 1, 2012, 00:00

  • DU4 Inappropriate Use of Drugs Influences Health Budget of Population

    Nov 1, 2012, 00:00

  • PRS41 Characteristics and Determinants of Palivizumab Use in the Netherlands

    Nov 1, 2012, 00:00

  • PMH56 Most Frequently Diagnosed Mental Health Problems in a German Population

    Nov 1, 2012, 00:00

  • PRS9 Allergies- Distribution and Perception in the German General Population

    Nov 1, 2012, 00:00

  • PMS19 Investigation of Comparative Clinical Outcomes Profiles and Cost Effectiveness of Four Classes of Anti Arthritic Drugs Using HAQ DI, DAS -28 and EQ5D3L in a Tertiary Care Hospital in Western India

    Nov 1, 2012, 00:00

  • PHP49 Irrational Use of Antibiotics in Children by Medical Prescribers

    Nov 1, 2012, 00:00

  • PHS6 Diagnosis Rates for Alzheimer's Disease in Taiwan in 2005 by Age Using National Health Insurance Claims Data

    Nov 1, 2012, 00:00

  • PMH1 Antagonistic Drug Prescribing- Cholinesterase Inhibitors and Anticholinergics

    Nov 1, 2012, 00:00

  • PCV94 The Influence of Disease-Specific Symptoms on the Health-Related Quality of Life in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM134 Regression Methods for Health-Related Quality of Life Data in Longitudinal Settings- Are More Advanced Techniques Really Performing Better?

    Nov 1, 2012, 00:00

  • PCN141 Health Care Utilization (HCU) by Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) Patients with Chemotherapy Induced Febrile Neutropenia (FN) in the Netherlands

    Nov 1, 2012, 00:00

  • PRS24 Cost-Effectiveness of Varenicline Compared With Bupropion and NRT (Nicorette) for Smoking Cessation in Austria

    Nov 1, 2012, 00:00

  • PMD65 The Cost Effectiveness of Hand Held Ultrasound Scanning for AAA in Elderly Subjects With a History of Smoking

    Nov 1, 2012, 00:00

  • PCV12 Determinants of Exposure to Potential Interactions Between Antiplatelet Drugs, Anticoagulants, Digoxin and Common Chinese Medications in Taiwan

    Nov 1, 2012, 00:00

  • PDB23 Economic Impact of Analogue Insulin on Health Expenditure at the Mexican Institute of Social Security in 2012. An Expenditure Reduction Proposal

    Nov 1, 2012, 00:00

  • PRM44 Increasing Life Expectancy- Implications for Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCV93 Study of the Use of Quality of Life Questionnaires in Cardiac Diseases in Poland

    Nov 1, 2012, 00:00

  • PMS53 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Kyphoplasty/Vertebroplasty Patients

    Nov 1, 2012, 00:00

  • PRS36 Content Validity of Two Symptom Questionnaires for Idiopathic Pulmonary Fibrosis

    Nov 1, 2012, 00:00

  • PHS52 Estimating the Resources Needed to Implement a Population-Based Colorectal Cancer Screening Program Through Discrete Event Simulation

    Nov 1, 2012, 00:00

  • PRS7 The Effect of Chronic Obstructive Pulmonary Disease (COPD) on Health Status in Urban China

    Nov 1, 2012, 00:00

  • PHP63 Potential Effects of Changes in Pricing Regulations Between 2004 and 2011 on the Turkish Pharmaceutical Industry

    Nov 1, 2012, 00:00

  • PMH4 Pharmacoepidemiology of Antidepressants in Elderly Patients- 12 Years of Experience

    Nov 1, 2012, 00:00

  • PIN79 Hepatitis C Virus Infection Increases the Risk of Alzheimer'S Diseases

    Nov 1, 2012, 00:00

  • PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in Belgium

    Nov 1, 2012, 00:00

  • PHP34 The Clinical Effectiveness and Resource Utilization of Drugs Which Contain Herbal Extracts – the Examples on Silymarin

    Nov 1, 2012, 00:00

  • PHP57 Clinical Effects of Pharmacist Interventions for Polypharmacy in a Geriatric Clinic in Taiwan

    Nov 1, 2012, 00:00

  • PHP134 Biosimilar Pricing- Past, Present and Future

    Nov 1, 2012, 00:00

  • PHP155 A Comparative Study of the Multiple Technology Assessment Process in the UK and Australia

    Nov 1, 2012, 00:00

  • PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 Participants

    Nov 1, 2012, 00:00

  • PHP119 Value and the Multiple Criteria Used in OECD Countries' Medicine Reimbursement Decision-Making Processes Using Health Economic Evidence

    Nov 1, 2012, 00:00

  • PHS68 An Assessment of Impairment of Productivity Among SLE Patients

    Nov 1, 2012, 00:00

  • PHP58 Direct Cost of Adverse Drug Reaction Treatment in Hospitalized Patients in Nakhon Pathom Hospital, Thailand

    Nov 1, 2012, 00:00

  • PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)

    Nov 1, 2012, 00:00

  • PCV41 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Knee Replacement

    Nov 1, 2012, 00:00

  • PHP40 Equity in Pharmaceutical Pricing and Reimbursement- Crossing the Income Divide in Asia Pacific

    Nov 1, 2012, 00:00

  • PHS90 How Do Pharmacists Advise Diabetes Patient Self-Management During the Holy Month of Ramadan?

    Nov 1, 2012, 00:00

  • PGI13 Economic Burden and Treatment Patterns of Adult Patients With Chronic Constipation Identified Through Retrospective Database Research

    Nov 1, 2012, 00:00

  • PRM61 External Validation of a Cardio-Vascular Disease Model

    Nov 1, 2012, 00:00

  • PDB55 The Adaptation of the Injection Pen Assessment Questionnaire for Use in Europe – Validation Results From a Large Multicenter Study of Recombinant Human Growth Hormone Treatment NaÏve Children and Adults

    Nov 1, 2012, 00:00

  • PRM13 Methods for Estimating Survival Benefits in the Presence of Treatment Crossover- A Simulation Study

    Nov 1, 2012, 00:00

  • PDB20 Safety of Preoperative Vitamin D Replacement in Mild Primary Hyperparathyroidism With Vitamin D Deficiency- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP104 A Correspondence Analysis of the Patient's Perspective on Shared Decision Making at the Family-Physician Unit

    Nov 1, 2012, 00:00

  • CL2 Usefulness of Days Lost Due to Disability As a New Method in Measuring Burden of Adverse Drug Reactions

    Nov 1, 2012, 00:00

  • PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • CV1 Cost-Effectiveness of a Nurse Facilitated Self-Management Programme for Heart Failure

    Nov 1, 2012, 00:00

  • PCV107 Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

    Nov 1, 2012, 00:00

  • PRM42 Multiple Criteria Decision Analysis for Health Technology Assessment

    Nov 1, 2012, 00:00

  • PHP192 Recent Global Insights Into Risk Sharing Agreements- A Comparative Analysis

    Nov 1, 2012, 00:00

  • PDB52 Adheren A Real World Retrospective Database Study Among Type 2 Diabetes Patients Treated With Liraglutide or Exenatide

    Nov 1, 2012, 00:00

  • PHP72 New Pricing Policies After Initiation of the Health Transformation Programme in Turkey

    Nov 1, 2012, 00:00

  • PHS96 The Impact of the Implementation of NICE Guidance on Venous Thromboembolism Risk Assessment and Patient Safety Across Four Hospitals in England

    Nov 1, 2012, 00:00

  • PCV23 Beta Blockers for Treatment of Chronic Heart Failure in Spain- Review of the Economic Evidence and Efficiency Analysis

    Nov 1, 2012, 00:00

  • PND59 Cross-Cultural Validation of the Huntington'S Disease Quality of Life Battery for Carers in France and Italy

    Nov 1, 2012, 00:00

  • PMD13 Projected Economic Impact of Utilizing Fractional Flow Reserve (FFR)-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Interventions (PCI) in Patients With Multivessel Coronary Disease- A Budget Impact Model

    Nov 1, 2012, 00:00

  • PDB53 Preliminary Results of a Multicenter Observational Study of Treatment Compliance With Free-Combination Versus Fixed Combination Treatment in Type II Diabetes Mellitus Patients in Greece (Less Study)

    Nov 1, 2012, 00:00

  • PMD71 The Switch Study- The Impact of Continuous Glucose Monitoring on Health Care Resource Utilization

    Nov 1, 2012, 00:00

  • PMS6 Disease Burden of Rheumatoid Arthritis in Mainland China- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV29 Long-Term Cost-Effectiveness of Ticagrelor in Patients with Acute Coronary Syndrome in Thailand

    Nov 1, 2012, 00:00

  • CL3 Anticoagulation Control of a Pharmacist Managed Anticoagulation Clinic in a National Referral Centre in Malaysia

    Nov 1, 2012, 00:00

  • MA4 Adequate Adherence to Intranasal Corticosteroids is Associated With Significantly Reduced Number and Costs of Outpatient Visits Among Patients Newly Diagnosed With Allergic Rhinitis

    Nov 1, 2012, 00:00

  • PCN47 Cost-of-Illness of Common Cancer Types - Results of a Health Insurance Claims Data Analysis

    Nov 1, 2012, 00:00

  • PCV109 Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain

    Nov 1, 2012, 00:00

  • PIN82 The Macro-Economic Impact of Reducing Malaria- An Application of a Dynamic General Equilibrium Modelling to Ghana

    Nov 1, 2012, 00:00

  • PSS15 A New Insight Into Cost-Effectiveness Analyses in Atopic Dermatitis- The Tacrolimus 0.1% Ointment Versus Ciclosporin Comparison

    Nov 1, 2012, 00:00

  • PND55 Multiple Sclerosis Impact Scale (MSIS-29)- Its Validity and Responsiveness in Clinical Trial-Based Subjects

    Nov 1, 2012, 00:00

  • PCN113 Assessing Health-Related Quality of Life (HRQoL) for Advanced Basal Cell Carcinoma (aBCC) and Basal Cell Carcinoma Nevus Syndrome (BCCNS)- Development of the First Disease-Specific Patient-Reported Outcome (PRO) Questionnaire

    Nov 1, 2012, 00:00

  • PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech Republic

    Nov 1, 2012, 00:00

  • PHP27 Implementation of the Transparency Directive in Hungary- Special Focus on Time Limits for Pricing and Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PHP195 Adoption of New Technologies in Twenty Established and Emerging Markets

    Nov 1, 2012, 00:00

  • PSY2 Effect of Intravenous Parecoxib on Postoperative Pain Relief After Total Knee Arthroplasty

    Nov 1, 2012, 00:00

  • PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Comparative Effectiveness Analysis Using Indirect Statistical Techniques

    Nov 1, 2012, 00:00

  • PIN7 Estimate of Infectious Disease Burden Attributable to Climate Change

    Nov 1, 2012, 00:00

  • PSY6 The Prevalence and Treatment Status of Hemophilia in Mainland China- A Systematic Review and Meta Analysis

    Nov 1, 2012, 00:00

  • PRM157 Methodological Challenges of IQWiG's Efficiency Frontier Concept Elicited by Multiple Patient-Relevant Endpoints – Why Prioritization of Endpoints Cannot Be Avoided

    Nov 1, 2012, 00:00

  • HT2 Cost-Effectiveness Analysis of Bone Mineral Density Screening Tools

    Nov 1, 2012, 00:00

  • PSS2 Comparisons of the Clinical Effectiveness of Treatments for Macular Oedema (MO) Caused by Retinal Vein Occlusion (RVO)

    Nov 1, 2012, 00:00

  • PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ)

    Nov 1, 2012, 00:00

  • PSU24 The Equivalence of Remote Electronic and Paper Collection of Patient Reported Outcomes (PROS)- A Crossover Trial

    Nov 1, 2012, 00:00

  • PHP99 Identifying Major Operational Causes and Potential Remedies for Emergency Department Over-Crowding-Crowding

    Nov 1, 2012, 00:00

  • PHP49 Down-Scheduling Medicines from Prescription to Over-the-Counter- Win-Win?

    Nov 1, 2012, 00:00

  • PDB38 Cost-Effectiveness of Insulin Detemir in People With Type 2 Diabetes in Romania

    Nov 1, 2012, 00:00

  • PMH14 Resilience Resources Predict Higher Quality of Life (QOL) Among Taiwanese Dialysis Patients

    Nov 1, 2012, 00:00

  • PMS75 Real-World Utilization Patterns of Rheumatoid Arthritis Medications in the United States- Anti-TNF Monotherapy and Adherence With Non-Biologic DMARDs in Combination with Anti-TNF Therapy

    Nov 1, 2012, 00:00

  • PMD38 The Cost Burden of Unexplained Syncope in Five European Countries- A Database Analysis

    Nov 1, 2012, 00:00

  • PCV46 The Pharmacoecomomic Analysis of Iloprost in Critical Limb Ischemia

    Nov 1, 2012, 00:00

  • PCN15 Clinical and Cost-Effectiveness of Proton Beam Radiotherapy for Eye Cancer- A Systematic Review

    Nov 1, 2012, 00:00

  • PCN19 Medical Management of Metastatic Renal Cell Carcinoma, Retrospective Analysis of Real World Data Settings

    Nov 1, 2012, 00:00

  • PIH10 Cost Effectiveness Comparison Between Dienogest and Gonadotropin-Releasing Hormone Analogs in Turkey

    Nov 1, 2012, 00:00

  • PHP17 Role of Subgroup Analyses for Technology Assessment and Coverage Decisions

    Nov 1, 2012, 00:00

  • PRS38 Turkish Cultural Adaptation and Validation of Smoking Cessation Quality of Life (SCQoL) Questionnaire

    Nov 1, 2012, 00:00

  • PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in Sweden

    Nov 1, 2012, 00:00

  • PMH3 Intravenous Droperidol and Olanzapine as Adjuncts to Midazolam for the Acutely Agitated Patient- A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Clinical Trial

    Nov 1, 2012, 00:00

  • PHS48 Cost-Effectiveness Analysis of Tolvaptan for Hyponatreamia in South Korea

    Nov 1, 2012, 00:00

  • PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting

    Nov 1, 2012, 00:00

  • PHS1 The Effect of Positioning and PNF-Exercise to Postoperative Bleeding After Hip Replacement

    Nov 1, 2012, 00:00

  • PIN3 Evaluation of the Relationship Between Vancomycin Trough Concentration and Clinical Outcome in Hospitalized Patients With Orsa Bacteremia and the Relationship Between Vancomycin Trough Concentration and Nephrotoxicity

    Nov 1, 2012, 00:00

  • PND7 Economic Impact of Dementia in the Community-Dwelling Elderly Population of Quebec (Canada)

    Nov 1, 2012, 00:00

  • PCN4 Role of 5-Alpha-Reductase Inhibitors, Statins, Aspirin, Nsaids on the Development of Prostate Cancer in Benign Prostatic Hyperplasia Patients-a Population Based Study

    Nov 1, 2012, 00:00

  • PRM118 Methodology for Neuropsychological Assessment Wordlist Adaptation

    Nov 1, 2012, 00:00

  • PMS19 Indirect Costs Associated With Ankylosing Spondylitis in Turkey

    Nov 1, 2012, 00:00

  • PMH47 Willingness to Pay for Key Attributes of the new Long Acting Injectable Treatments in Schizophrenia

    Nov 1, 2012, 00:00

  • HT4 Health Technology Assessment Map in Asia – Regional Versus International Influences

    Nov 1, 2012, 00:00

  • PCN62 Cost Impact Modeling of Targeted Molecular Profiling in the Treatment of Colon Cancer

    Nov 1, 2012, 00:00

  • PUK3 Evaluation on Health Expenditure Among Patients With Neurogenic Detrusor Overactivity After Spinal Cord Injury

    Nov 1, 2012, 00:00

  • PRM70 What If All Other Things are Not Equal? – Accounting for Future Changes in the Decision Context When Extrapolating Cost-Effectiveness Results Over Time

    Nov 1, 2012, 00:00

  • PMS7 The Medication Costs of Rheumatoid Arthritis - Comparing Before and After Introduction of the Biologics

    Nov 1, 2012, 00:00

  • PDB7 Clinical and Resource Utilization Outcomes- Elderly Type 2 Diabetes Patients Initiating Insulin Pens Versus Vials

    Nov 1, 2012, 00:00

  • PIN13 The Clinical Burden of Hospitalized All-Cause Pneumonia in the Lombardia and Puglia Regions of Italy, 2007–2009

    Nov 1, 2012, 00:00

  • PHP140 Challenges in the Data Collection Regarding Patient Population and Treatment Costs for Non-Drug Interventions Using the Example of Morbus Dupuytren

    Nov 1, 2012, 00:00

  • PRS35 The Economic Burden of HAE- Findings From the HAE Burden of Illness Study in Europe (HAE-BOIS-Europe)

    Nov 1, 2012, 00:00

  • PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

    Nov 1, 2012, 00:00

  • PMH9 Cost Consequences of Non-Compliance in Schizophrenia Treatment – A Literature Review

    Nov 1, 2012, 00:00

  • PCN48 The Cost of Treating Penile Cancer in English Hospitals- Preliminary Results Using the Hospital Episodes Statistics (HES) Database

    Nov 1, 2012, 00:00

  • PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

    Nov 1, 2012, 00:00

  • PCV36 Validation 36 and Comparison of the SF-6D and EQ-5D in Chinese Patients With Stable Angina Pectoris

    Nov 1, 2012, 00:00

  • PSU36 Evidence Based Medicine- A Case Study of its Application to Innovative Surgical Procedures in the UK

    Nov 1, 2012, 00:00

  • PIN31 Burden of Disease and Economic Impact of Dengue and Severe Dengue in Colombia- 2011

    Nov 1, 2012, 00:00

  • PMD52 Diagnostics in Cost-Effectiveness Analysis- The Evaluation of the EOS 2D/3D X-Ray Imaging System

    Nov 1, 2012, 00:00

  • PCN10 Risk of Breast Cancer and Statins- A Population-Based Nested Case-Control Study in Chinese Population

    Nov 1, 2012, 00:00

  • PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With Diverticulitis

    Nov 1, 2012, 00:00

  • PND16 Cost-Effectiveness Analysis of Lacosamide as Adjunctive Therapy in Adults With Partial-Onset Seizures in Mexico

    Nov 1, 2012, 00:00

  • PMS51 Work Productivity and Productivity Costs of Patients With Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis in the Czech Republic

    Nov 1, 2012, 00:00

  • PMH8 Cost of Methylphenidate and Atomoxetine Prescribing to Children and Adults in South Africa

    Nov 1, 2012, 00:00

  • PIN45 Health Economic Impact of Infant Vaccination Program With PHiD-CV and PCV13 Using New Efficacy/Effectiveness Data. Example of Finland

    Nov 1, 2012, 00:00

  • PRM99 Translation and Validation of Osteoporosis Self-Efficacy Scale Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PIN66 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in São Paulo State, Brazil – Public Perspective

    Nov 1, 2012, 00:00

  • PRM174 The Need to Conduct Future Research on the Benefit of the Prostate Specific Antigen Screening Test Using the Value of Information Framework

    Nov 1, 2012, 00:00

  • PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars- The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

    Nov 1, 2012, 00:00

  • PRM36 A Chinese Population-Based Study on Preferences for Health States- How Individual Characteristics Matter?

    Nov 1, 2012, 00:00

  • PSY1 Burdens of Psoriasis in the Asia Pacific Region- A Literature Review

    Nov 1, 2012, 00:00

  • PMH5 Does Participation in a Weight Control Program Also Improve Clinical and Functional Outcomes for Chinese Patients with Schizophrenia Treated with Olanzapine?

    Nov 1, 2012, 00:00

  • PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea- A Pilot Study

    Nov 1, 2012, 00:00

  • PIN14 Cost of Treatment for Patient With HIV AIDS in Hospital of East Java, Indonesia

    Nov 1, 2012, 00:00

  • PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RA

    Nov 1, 2012, 00:00

  • PRS33 Factors Affecting Adherence to COPD Therapy in 5EU

    Nov 1, 2012, 00:00

  • PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany

    Nov 1, 2012, 00:00

  • PDB25 Evaluation of Health Care Cost of Diabetes Before and After Counseling in South Indian Community Setup

    Nov 1, 2012, 00:00

  • PGI4 Assessing the Use of a Harmonic Scalpel in Laparoscopic Cholecystectomy- A Systematic Review of the Evidence

    Nov 1, 2012, 00:00

  • PMD80 Preferences for a New Imaging Technique to Detect Breast Cancer

    Nov 1, 2012, 00:00

  • PIH2 Topical Estrogen Therapy in Postmenopausal Women - Indian Experience

    Nov 1, 2012, 00:00

  • PGI32 New Antiviral Drugs for Hepatitis C in Italy- Will it be a Treasure Hunt?

    Nov 1, 2012, 00:00

  • PCN74 Cost Effectiveness of Cyclophosphamide in the Adjuvant Treatment of Breast Cancer in Europe- A Multi-Country Study

    Nov 1, 2012, 00:00

  • PHP95 Efficiency of Greek Hospitals- Best Practices of Three Top-Performing Hospitals

    Nov 1, 2012, 00:00

  • PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PMS79 Evaluation of Current Health Technology Assessments for Rheumatoid Arthritis – an Insight Into the Key Uncertainties Generated by the Available Evidence

    Nov 1, 2012, 00:00

  • PHP56 The Role of Antineoplastic and Immunomodulating Agents in Works and Recommendations of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011

    Nov 1, 2012, 00:00

  • PND32 Economic Evaluation of Natalizumab for the Treatment of Multiple Sclerosis in Mexico

    Nov 1, 2012, 00:00

  • PND73 Multiple Sclerosis in Germany- Outpatient Health Care Patterns

    Nov 1, 2012, 00:00

  • PGI9 Pharmacoeconomic Evaluation of Antyhelicobacter Therapy of Ulcers Duodenum in Ukraine

    Nov 1, 2012, 00:00

  • PHS63 Patient Perception of an Oral Systemic Anti-Cancer Therapy Homecare Service

    Nov 1, 2012, 00:00

  • PND58 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Confirm Study

    Nov 1, 2012, 00:00

  • PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

    Nov 1, 2012, 00:00

  • CA2 Applying a Value-Based Price Across Different Disease Areas

    Nov 1, 2012, 00:00

  • CL1 A Novel Method for Calculating Prevalence of Multiple Sclerosis in Australia

    Nov 1, 2012, 00:00

  • PMH58 The Impact of ADHD Medication Attributes on Physician Prescribing Behavior in the EU- Results From Chart-Reviewed Data

    Nov 1, 2012, 00:00

  • PMD11 The Cost of Poor Sample Quality- Assessing the Financial Impact of Sample Rejection and Recollection in Health Care Insitutions

    Nov 1, 2012, 00:00

  • PND21 Multiple Sclerosis in Russian Federation- Evaluation of Social and Economical Burden in Real Clinical Practice

    Nov 1, 2012, 00:00

  • PHP112 Estimating the Probability of a Favorable Assessment of Clinical Benefits for a New Drug in Germany Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PIH22 Clinical Efficacy and Cost-Effectiveness of Human Recombinant Interferon-α2B in Neonatal Infections

    Nov 1, 2012, 00:00

  • PHS77 Cancer Network Pharmacists Perspective of the First Year of the Cancer Drugs Fund

    Nov 1, 2012, 00:00

  • PCN128 Estimating the Value of Companion Diagnostics- Are the Incentives Right?

    Nov 1, 2012, 00:00

  • PHP123 Importance of Health-Related Quality of Life As an Endpoint in Benefit Assessment According to the German AMNOG

    Nov 1, 2012, 00:00

  • PRM20 Empirical Analysis Shows Reduced Cost Data Collection May Be an Efficient Method in Economic Clinicl Trials

    Nov 1, 2012, 00:00

  • PSY20 Infliximab Significantly Improves Symtoms and Quality of Life in Patients With Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PND6 Economic Burden of Structural-Metabolic Epilepsy in Malaysia

    Nov 1, 2012, 00:00

  • PHP118 The Attitude of Farmers to the New Rural Cooperative Medical Scheme in the Northwest of China- A Cross-Sectional Study

    Nov 1, 2012, 00:00

  • PIN81 Perceptions of Hospital Pharmacists Regarding Effective Anti-Malarial Drug Management in Pakistan. A Qualitative Insight

    Nov 1, 2012, 00:00

  • PGI13 Vaccination Status Against Hepatitis B Among Healthy Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PHP200 Effective Demand for a Health Literate Health Care System - Evidence from Irish Survey Data

    Nov 1, 2012, 00:00

  • PHP91 Using Observational Comparative Effectiveness Studies to Inform Decision Making- The Need for a Two-Phase Approach to Assessing Quality and Appropriateness

    Nov 1, 2012, 00:00

  • PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision Making

    Nov 1, 2012, 00:00

  • PIN54 Evaluation of Skin Tests in the Diagnostics of Tuberculosis Infection

    Nov 1, 2012, 00:00

  • PRS2 A Retrospective Epidemiologic Review of COPD in Korea

    Nov 1, 2012, 00:00

  • PDB56 Development and Validation of Patient Reported Endpoints for T2DM

    Nov 1, 2012, 00:00

  • PIH7 Immunization Providers' Cost and Vaccination Cost in Iraq

    Nov 1, 2012, 00:00

  • PND37 The Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) for the Treatment of Acute Epileptic Seizures in the UK; a Hybrid Model Solution

    Nov 1, 2012, 00:00

  • PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in Germany

    Nov 1, 2012, 00:00

  • PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients- An Exploratory Economic Evaluation of Personalized Medicine

    Nov 1, 2012, 00:00

  • PSU35 Epidemiological Modeling of Patient Survival After Heart Transplantation in Germany

    Nov 1, 2012, 00:00

  • PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

    Nov 1, 2012, 00:00

  • PCN84 Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer- An Economic Evaluation in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PCN123 A Conjoint Analysis of Willingness to Pay to Avoid Metastatic Breast Cancer Side Effects

    Nov 1, 2012, 00:00

  • PND7 Off-Label Use of Antiepileptic Drugs and its Costs – a Drug Utilization Study in Portugal

    Nov 1, 2012, 00:00

  • PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany

    Nov 1, 2012, 00:00

  • PHP22 Off-Label Use of Intravenous Non-Steroidal Anti-Inflammatory Drugs-Ketorolac in a Nationally Representative Population

    Nov 1, 2012, 00:00

  • PCV99 EQ-5D Utilities in Patients Hospitalised With Heart Failure in Canary Islands

    Nov 1, 2012, 00:00

  • PSU22 Health-Related Quality of Life in Prostate Cancer - Comparison of Robot-Assisted and Open Surgery

    Nov 1, 2012, 00:00

  • PHP27 The Effect of Retirement on Mental Health

    Nov 1, 2012, 00:00

  • PMS44 Cost-Effectiveness of Alendronate Therapy Forcorticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PSS34 Impact of Specialty on Patient-Physician Interaction and Treatment Patterns- An on-Line Study of Eczema Patients

    Nov 1, 2012, 00:00

  • PCV9 Meta-Analysis of the Efficacy and Safety of Stevioside (from Stevia Rebaudiana Bertoni) in Blood Pressure Control in Patients With Hypertension

    Nov 1, 2012, 00:00

  • PHS14 Clinical and Economic Analysis of “MoliCare® Premium Extra Soft” Diapers Efficient Application for Dermatitis and Pressure Ulcers' Prophylaxis for Immobile Urinary-Incontinent Patients

    Nov 1, 2012, 00:00

  • PHP156 Amnog – Summary of Outcomes of Early Benefit Assessment and Reimbursement Negotiation for New Drugs in Germany

    Nov 1, 2012, 00:00

  • PRM23 Discriminative Properties of SF36v2 Health Survey in General Population of Penang State (Malaysia) Using Norm Based Scoring Algorithms

    Nov 1, 2012, 00:00

  • PIN11 Economic Burden of Invasive Pneumococcal Diseases in Urban China

    Nov 1, 2012, 00:00

  • PRS47 Analysis of New Prescriptions for Long-Acting β2-Agonists in Five European Countries in 2011

    Nov 1, 2012, 00:00

  • ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in Australia

    Nov 1, 2012, 00:00

  • PMD8 One Year Evaluation of Effectiveness and Device Complication Outcomes in the Helping Evaluate Reduction in Obesity (HERO) Study

    Nov 1, 2012, 00:00

  • PHP76 Evidence Requirements for Pricing and Reimbursement Decision Making for Orphan Drugs in Asia

    Nov 1, 2012, 00:00

  • PIN37 The Economic Burden of Initial Empiric Antibiotic Failure on Health Care Resource Utilization for Hospitalized Patients With Complicated Intra-Abdominal Infections (cIAIs) in Greece

    Nov 1, 2012, 00:00

  • PCN153 Application of Real World Data to Inform a Breast Cancer Decision - Analytic Model in Austria and the U.S - Preliminary Outcomes of Data Collection

    Nov 1, 2012, 00:00

  • PRM55 Third Party Model Validity- A Review and Survey of Face and Internal Validity of Health Economic Models

    Nov 1, 2012, 00:00

  • PRM159 Sensitivity Analysis Versus Uncertainty Analysis in Health Economic Decision Making

    Nov 1, 2012, 00:00

  • PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing?

    Nov 1, 2012, 00:00

  • PRM127 Measuring Quality of Life in Mental Health- Issues and Challenges

    Nov 1, 2012, 00:00

  • PRM44 Clinical and Comparative Economic Value - A Novel Pharmacoeconomic Analysis Embedded in the Drug Development Process

    Nov 1, 2012, 00:00

  • PHP116 Equity in the New Rural Cooperative Medical Scheme- Comparison of Benefit Packages for Chronic Disease Outpatients in 32 Counties in China

    Nov 1, 2012, 00:00

  • PHP161 Integration of Value of Information Into the Decision Making Process in Ireland

    Nov 1, 2012, 00:00

  • PHP105 Impact of Clinical Pharmacy Program on Prescription Errors in a Lebanese Institution- A Cost Benefit Analysis

    Nov 1, 2012, 00:00

  • PIN23 Economic Analysis of Atazanavir as 1st Line Treatment for VIH Patients, on Stable and Sever Health State

    Nov 1, 2012, 00:00

  • PSS4 Acne and Lifestyle- Results of a Survey on a Representative Sample of the French Population

    Nov 1, 2012, 00:00

  • PHP19 Consumption of Drugs for Peptic Ulcer and Gastroesophageal Reflux Disease- Striking Differences Between Serbia and Norway

    Nov 1, 2012, 00:00

  • PHP145 Using an Evidence Database of Previous Nice HTA Decisions to Maximise Re-Review Strategy

    Nov 1, 2012, 00:00

  • PIN49 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Elderly Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PIH49 Population Access to Rotavirus Vaccination in Developped Countries- Lessons Learned from Current Experience and Potential Implications for the Future

    Nov 1, 2012, 00:00

  • PMH49 Horizon Scanning of Molecular Imaging Methods in Psychiatric Disorders

    Nov 1, 2012, 00:00

  • PCV36 Increasing Costs for German Social Health Insurance (SHI) Funds by Abandonment of Pentaerithrityltetranitrat (PETN) for Patients With Coronary Heart Disease (CHD)? – A Cost Analysis Based on Sick Fund Data

    Nov 1, 2012, 00:00

  • PCV70 Cost-Effectiveness of Smoking Cessation Interventions in Smokers With Cardiovascular Disease in the Netherlands

    Nov 1, 2012, 00:00

  • EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011- Some Success, Many Unintended Effects

    Nov 1, 2012, 00:00

  • PGI22 Cost-Effectiveness Analysis of Dexlansoprazole for the Treatment of Erosive Esophagitis Compared to Conventional Proton Pump Inhibitors

    Nov 1, 2012, 00:00

  • PMD10 Analysis of Costs of Complications for Stroke Prevention in Atrial Fibrillation Patients, Comparing Dose-Adjusted Warfarin to Left Atrial Appendage Closure

    Nov 1, 2012, 00:00

  • PRM32 Development of a Post-Marketing Requirements (PMR) Database

    Nov 1, 2012, 00:00

  • PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PND42 Cost-Effectiveness of Onabotulinumtoxin-a for the Prophylaxis of Chronic Migraine

    Nov 1, 2012, 00:00

  • PMS3 Improvements in Patient-Reported Pain and Global Disease Activity in Rheumatoid Arthritis Patients After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial

    Nov 1, 2012, 00:00

  • PHP64 Evaluation of Public Perception Towards Medicine Quality and Prices in Afghanistan

    Nov 1, 2012, 00:00

  • PDB9 Outcome of Fixed Dose Radioactive Iodine for the Treatment of Hyperthyroidism

    Nov 1, 2012, 00:00

  • PUK20 Development of a Patient Adherence Specific Scale for Use in the Management of Benign Prostatic Hyperplasia Patients

    Nov 1, 2012, 00:00

  • PHP197 Opportunities and Limitations of Sustainability Indices in Satisfying the Needs of Health Technology Purchasers Seeking Objective and Unbiased Indicators of Environmental and Societal Impacts

    Nov 1, 2012, 00:00

  • PCN150 Comparisons of QALYs Gained, Cost Per QALY Gained and ASMRs for 38 Anticancer Drugs in France and the UK- Vive La Difference?

    Nov 1, 2012, 00:00

  • PHP178 Validity of Self-Reported Health Care Utilization- Towards a Research Consensus

    Nov 1, 2012, 00:00

  • PSY13 Systematic Review of the Economic and Epidemiological Burden of Bleeding-Related Complications in Hong Kong

    Nov 1, 2012, 00:00

  • PRM13 Overview of PRO Instruments from the PROQOLID Database for Use in Taiwan

    Nov 1, 2012, 00:00

  • PSY27 A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and II Hereditary Angioedema in the UK Setting

    Nov 1, 2012, 00:00

  • PDB30 The Pattern and Prescription Cost Among Diabetic Patients in the HO Municipal Hospital, Volta Region, Ghana

    Nov 1, 2012, 00:00

  • PHP112 Usage of Self-Monitoring of Blood Glucose (SMBG) by Diabetes Therapy Type in Larger Cities in China

    Nov 1, 2012, 00:00

  • PHP151 The Influence of Patient Compliance Arguments in Nice Technology Appraisals

    Nov 1, 2012, 00:00

  • PDB13 Bariatric and Metabolic Surgery in China – Efficacy of Minimally Invasive Procedures

    Nov 1, 2012, 00:00

  • PDB40 The Importance of HbA1C Evolution in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies- Problems and Solutions

    Nov 1, 2012, 00:00

  • PCV77 Analysis of Hospital-Specific Drg Payments for Stroke According to United States Medicare Perspective

    Nov 1, 2012, 00:00

  • VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

    Nov 1, 2012, 00:00

  • PRM34 Routine Data in HTA- Record Linkage in Austrias GAP-DRG Database

    Nov 1, 2012, 00:00

  • PCV82 Observational Study Evaluating the Level of Compliance With Antihypertensive Drugs in the Greek Population

    Nov 1, 2012, 00:00

  • PHP76 Use of Estimates in the Economic Model of the Impact of New Health Coverage in Private Brazilian Market

    Nov 1, 2012, 00:00

  • PHP114 Review of Cost Effectiveness Studies of High Budget Impact Drugs (2007-2012)

    Nov 1, 2012, 00:00

  • PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province

    Nov 1, 2012, 00:00

  • PRM162 Appropriate Comparative Treatments for Early Benefit Assessment (EBA) in Germany. Comparing the Suggestions by the Joint Federal Committee (GBA) and the Pharmaceutical Companies

    Nov 1, 2012, 00:00

  • PSU23 Women's Preferences for Breast Reconstruction- A Study Using a Discrete Choice Experiments

    Nov 1, 2012, 00:00

  • PHS15 Recommendation for Rotavirus Vaccination and Herd Effect- Analyzing Cost Data from a German Statutory Health Insurance

    Nov 1, 2012, 00:00

  • PR4 Trends in Pricing and Reimbursement Schemes From 1994-2011

    Nov 1, 2012, 00:00

  • PIN60 Critical Review of Cost-Effectiveness Analyses of Human Papillomavirus Vaccine in Boys

    Nov 1, 2012, 00:00

  • PHP114 Failure for Cost-Sharing Schemes to Take Off in India- What Can Be the Access Solution?

    Nov 1, 2012, 00:00

  • PHP115 The Sharp Decrease of Drug's Access to Reimbursement in France in 2011

    Nov 1, 2012, 00:00

  • PMS10 Hospitalization Costs and Their Predictors in Patients with Rheumatoid Arthritis in Urban China

    Nov 1, 2012, 00:00

  • PMS60 The Time Horizon Matters- Exploratory Results Varying the Time Horizon in Time Trade-Off and Standard Gamble Utility Elicitation

    Nov 1, 2012, 00:00

  • PRM18 Modeling Long-Term Health Outcomes in Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish Results

    Nov 1, 2012, 00:00

  • PGI7 the Cost-Effectiveness of Rotavirus Vaccination in Guangzhou, China

    Nov 1, 2012, 00:00

  • PHP105 Guideline Implementation in Long Term Asthma Management- An Audit Using a Medication Assesssment Tool in Selayang Hospital

    Nov 1, 2012, 00:00

  • PSS22 Impact of Patient Satisfaction on Health Related Quality of Life, in Psoriasis Patients Receiving Traditional Systemic Therapy

    Nov 1, 2012, 00:00

  • PCN21 Comparative Effectiveness and Cost-Effectiveness Assessment of Erlotinib Versus Gefitinib in First-Line Treatment of EGFR Activating Mutation Positive Non-Small Cell Lung Cancer for Hong Kong

    Nov 1, 2012, 00:00

  • PMH50 Differences in Treatment Patterns and Characteristics in Patients With Bipolar Disorder - A Retrospective Real Life Study in Sweden

    Nov 1, 2012, 00:00

  • PUK22 Evaluating the Minimum Renal Allograft Survival Time Required for Transplantation to Remain Cost Saving in the UK

    Nov 1, 2012, 00:00

  • PIH5 Preventable Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities - A Systematic-Review

    Nov 1, 2012, 00:00

  • PHP50 Integrated Closed Intravenous Catheter System Reduces the Occurrence of the Catheter Replacement and the Cost

    Nov 1, 2012, 00:00

  • PMH15 An Economic Systematic Review on Bipolar Disorder in Children and Adolescents- Cost-Effectiveness of Treatments, Costs of Care and Quality of Life

    Nov 1, 2012, 00:00

  • PSU34 Epidemiological Modeling of Patient Survival After Liver Transplantation in Germany

    Nov 1, 2012, 00:00

  • PHS82 Determinants of Health Service Utilization in Urban Pakistan

    Nov 1, 2012, 00:00

  • PRM24 Economic Valuation of Informal Care – Task Based Approach

    Nov 1, 2012, 00:00

  • PHS24 Cost of Traffic Accidents Related to Low Visibility Conditions- A Cost of Illness Study

    Nov 1, 2012, 00:00

  • PSU27 Liver Transplantation in Familial Amyloid Polyneuropathy in Brazil- Demographic and Clinical Data Compared to FAP World Transplant Registry

    Nov 1, 2012, 00:00

  • PHS25 Direct Medical Costs of Medical Care of Gastrointestinal Bleeding in Mexico

    Nov 1, 2012, 00:00

  • PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model

    Nov 1, 2012, 00:00

  • PIH27 Cost Analysis of Neonatal and Pediatric Parenteral Nutrition in Belgium

    Nov 1, 2012, 00:00

  • PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHP110 Gaining Reimbursement of Orphan Products in Europe- Challenges Due to Wide Variations in Evidence Requirements and Processes

    Nov 1, 2012, 00:00

  • PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PIN12 The Analysis for Inpatients Cost and Medical Insurance Coverage of Pneumonia in China, 2009

    Nov 1, 2012, 00:00

  • PRS45 Health Outcomes and Costs of Patients With Chronic Obstructive Pulmonary Disease According to the Continuity of Ambulatory Care With Korean National Health Insurance Database

    Nov 1, 2012, 00:00

  • PSY35 Assessment of the Most Bothersome Symptoms and Impacts Reported by Patients With Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

    Nov 1, 2012, 00:00

  • PHS76 An Infuenza Vaccination Policy Based on a Previous Year's Illness

    Nov 1, 2012, 00:00

  • PRM145 A Maximum Likelihood Simulation Technique for Estimating Adverse Event Rates From Published Trials

    Nov 1, 2012, 00:00

  • PSS11 Economic Evaluation of Biologic Treatments for Moderate to Severe Psoriasis in Italy

    Nov 1, 2012, 00:00

  • PIN44 Cost-Effectiveness of Posaconazole Compared to Fluconazole/Itraconazole for the Prevention of Invasive Fungal Infections in Neutropenic Patients

    Nov 1, 2012, 00:00

  • PHP109 Evaluation of the Use of Sedation for Adults Using Mechanical Ventilators in a Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PIN75 Health-Related Quality of Life of Clostridium Difficile Infection- A Methodological Contribution to Direct Utility Elicitation by TTO

    Nov 1, 2012, 00:00

  • PHP142 Drug Shortages Around the World and the Underlying Reasons

    Nov 1, 2012, 00:00

  • PCV24 The Practical Assessment of Same-Day Discharge With Scheduled Trans-Radial Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • PND18 Impact of Co-Morbidities on the Economic Burden of Parkinson'S Disease in Germany Post-2000

    Nov 1, 2012, 00:00

  • PDB35 Validation of the Problem Areas in Diabetes Questionnaire Among Patients With Type 2 Diabetes Mellitus in Singapore- a Pilot Study

    Nov 1, 2012, 00:00

  • PRM149 A Random Utlity Model Using a Transaction Cost Politics Approach to Adjust Health Systems to Economic Transition

    Nov 1, 2012, 00:00

  • PSY15 Effectiveness of Fresh Frozen Plasma and Its Cost-Effectiveness in Iranian Acute Organophosphate Poisoning Patients

    Nov 1, 2012, 00:00

  • UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder- Response to Stimulant Treatment

    Nov 1, 2012, 00:00

  • PHS43 Cost-Effectiveness Analysis of Therapeutic Drug Monitoring in Pediatric Patients Diagnosed With Structural-Metabolic Epilepsy

    Nov 1, 2012, 00:00

  • PCN104 Profile of Patients and Health Care Costs Associated With Cancer Treatment From a Medical Cooperative in the State of São Paulo, Brazil

    Nov 1, 2012, 00:00

  • PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan- The Japan National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PHP121 Drug Reimbursement Maintenan A French Challenge in 2011

    Nov 1, 2012, 00:00

  • PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein Testing

    Nov 1, 2012, 00:00

  • PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy

    Nov 1, 2012, 00:00

  • PCN26 Geographic Variation Associated with Colorectal Cancer Prevalence in the United States

    Nov 1, 2012, 00:00

  • PRM77 Mapping the Meanings of Words Patients Use to Describe Their Pain

    Nov 1, 2012, 00:00

  • PIH39 Occupational Stress and Burnout- Impact on the Attitudes of Pharmacists in Providing Pharmaceutical Services

    Nov 1, 2012, 00:00

  • PRM131 How Might Experience-Based Utility Measures Influence Reimbursement Decisions?

    Nov 1, 2012, 00:00

  • PMD21 Cost Comparison of Spinal Fusion Procedures With Grafton Mixed With Local Bone Compared to Iliac Crest Bone

    Nov 1, 2012, 00:00

  • CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

    Nov 1, 2012, 00:00

  • PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?

    Nov 1, 2012, 00:00

  • PDB22 Potential Budget Impact of Linagliptin in France Estimated From Current Pattern of Dipeptidyl Peptidase 4 Inhibitors Prescriptions

    Nov 1, 2012, 00:00

  • PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PDB16 Geographic Variation Trends in Diabetes Mellitus Prevalence in the United States Veteran Population

    Nov 1, 2012, 00:00

  • DU3 Market Access Delays for CNS Drugs in Europe

    Nov 1, 2012, 00:00

  • PCN78 Cost-Effectiveness of Plerixafor Plus GCSF for Mobilization of Peripheral Blood Stem Cells in Patients With Myeloma and Lymphoma in Spain

    Nov 1, 2012, 00:00

  • PCV66 Pharmacoeconomic Analysis of Azilsartan Medoxomil in Patients With Arterial Hypertension- Comparison With Valsartan, Telmisartan, Losartan and Irbesartan in the Mexican Context

    Nov 1, 2012, 00:00

  • PIN87 Lengt of Stay and Costs for Patients With Recurrent Clostridium Difficile Infections in Sweden

    Nov 1, 2012, 00:00

  • PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective

    Nov 1, 2012, 00:00

  • PRM161 A Paradigm Shift in Health Economic Evaluations for Developing Countries - Optimization Modelling for Assessing Which Mix of Malaria Prevention Strategies Achieves a Defined Public Health Target at the Lowest Budget

    Nov 1, 2012, 00:00

  • PIN28 Cost-of-Illness Analysis of Candidemia in Patients on the Intensive Care Unit

    Nov 1, 2012, 00:00

  • PCN49 Economic Burden of Melanoma in Russia

    Nov 1, 2012, 00:00

  • PMD93 Practice Variation in Diagnostic Imaging Workup and Treatment Criteria Following a Recent TIA or Minor Ischemic Stroke- Consequences for Early Economic Evaluations

    Nov 1, 2012, 00:00

  • PMS23 Health Related Quality of Life, Measured by the Short Form-36, of Patients with Rheumatoid Arthritis and Ankylosing Spondylitis in an Urban Population of China

    Nov 1, 2012, 00:00

  • PMD46 Economic Analysis of a Predictive Test for Taxane Response in Early Breast Cancer Patients in the UK

    Nov 1, 2012, 00:00

  • PMH11 Costs of Children With Attention Deficit Hyperactivity Disorder (ADHD) Being Compliant or Non-Compliant to Pharmacological Treatment- Results From a Dutch Observational Study

    Nov 1, 2012, 00:00

  • PIN18 Antimicrobial Resistance (AMR) in Thailand- A Systematic Review

    Nov 1, 2012, 00:00

  • PCV43 Fair Cost-Benefit Evaluation of Health Care- A Case Study of Blood Pressure Lowering Drugs in France

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114 (current)
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »